Publication
PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer
Journal Paper/Review - Sep 8, 2014
Loibl Sibylle, Fasching Peter A, Andre Fabrice, Lindner Judith L, Sotiriou Christos, Dykgers August, Guo Sanxing, Gade Stephan, Nekljudova Valentina, Loi Sherene, Untch Michael, Pfitzner Berit, Huober Jens, Heinrichs Clemens, von Minckwitz Gunter, Schneeweiss Andreas, Paepke Stefan, Lehmann Annika, Rezai Mahdi, Zahm Dirk M, Sinn Peter, Khandan Fariba, Eidtmann Holger, Dohnal Karel, Denkert Carsten
Loibl, Sibylle
84
0
von Minckwitz, Gunter
59
0
Schneeweiss, Andreas
77
0
Paepke, Stefan
12
0
Lehmann, Annika
1
0
Rezai, Mahdi
15
0
Zahm, Dirk M
2
0
Sinn, Peter
5
0
Khandan, Fariba
5
0
Eidtmann, Holger
26
0
Dohnal, Karel
1
0
Heinrichs, Clemens
2
0
Huober, Jens
chief physicianBrustzentrum St.Gallen, Medizinische Onkologie und Hämatologie · Dept. IV, Dept. I
298
12
Pfitzner, Berit
2
0
Fasching, Peter A
74
0
Andre, Fabrice
1
0
Lindner, Judith L
1
0
Sotiriou, Christos
12
0
Dykgers, August
1
0
Guo, Sanxing
1
0